Tekla Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,109
| Closed | -$61K | – | 192 |
|
|
2017
Q4 | $61K | Hold |
1,109
| – | – | ﹤0.01% | 160 |
|
|
2017
Q3 | $47K | Hold |
1,109
| – | – | ﹤0.01% | 152 |
|
|
2017
Q2 | $47K | Hold |
1,109
| – | – | ﹤0.01% | 143 |
|
|
2017
Q1 | $62K | Hold |
1,109
| – | – | ﹤0.01% | 138 |
|
|
2016
Q4 | $42K | Hold |
1,109
| – | – | ﹤0.01% | 142 |
|
|
2016
Q3 | $44K | Hold |
1,109
| – | – | ﹤0.01% | 141 |
|
|
2016
Q2 | $80K | Hold |
1,109
| – | – | ﹤0.01% | 140 |
|
|
2016
Q1 | $89K | Hold |
1,109
| – | – | ﹤0.01% | 139 |
|
|
2015
Q4 | $84K | Hold |
1,109
| – | – | ﹤0.01% | 132 |
|
|
2015
Q3 | $425K | Hold |
1,109
| – | – | 0.02% | 132 |
|
|
2015
Q2 | $461K | Hold |
1,109
| – | – | 0.02% | 104 |
|
|
2015
Q1 | $527K | Sell |
1,109
-1,109
| -50% | -$527K | 0.02% | 98 |
|
|
2014
Q4 | $821K | Buy |
+2,218
| New | +$821K | 0.04% | 88 |
|